AG
Agenus Inc.
AGEN · NASDAQ
$9.93 +0.10% (+$0.01)
1M +24.28%
Market Cap $413.5M
P/E Ratio 4.49x
Div. Yield -
ROE -
Bulios Fair Price
$7.24
27.1% downside
Current Price
$9.93
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AGEN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
92 /100
Cheap P/E 4.49x
EV/EBITDA 2.80x
P/S 3.12x
Growth
46 /100
Stable Rev. growth 5.22%
EPS growth N/A
FCF growth N/A
Profitability
70 /100
Strong Gross margin 75.63%
Net margin 69.34%
Op. margin 27.28%
Quality
35 /100
Average ROIC 129.48%
ROA 53.28%
Asset turnover 0.77x
Debt
59 /100
Moderate Current ratio 0.34x
Int. coverage 2.56x
Net debt/EBITDA 0.14x
Stability
22 /100
Unstable Beta 1.55x
Rev. volatility 46.66%
EPS volatility 47.90%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AGEN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Garo H. Armen
Employees
81
Headquarters
Lexington
Upcoming events
09 NOV
Earnings
Upcoming earnings report